Molecular genetic pathways in Parkinson's disease: a review

被引:27
|
作者
Jain, S
Wood, NW
Healy, DG
机构
[1] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England
[2] NIA, NIH, Bethesda, MD 20892 USA
[3] UCL, Reta Lila Weston Inst Neurol Sci, London W1T 4JF, England
关键词
alpha-synuclein; dardarin; genetic basis; Lewy body; Mendelian genetics; parkin; Parkinson's disease;
D O I
10.1042/CS20050106
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Major progress has been made in the last decade in understanding the genetic basis of PD (Parkinson's disease) with five genes unequivocally associated with disease. As a result, multiple pathways have been implicated in the pathogenesis of PD, including proteasome impairment and mitochondrial dysfunction. Although Mendelian genetics has been successful in establishing a genetic predisposition for familial PD, this has not been reiterated in the sporadic form. In fact no genetic factors have been unequivocally associated with increased risk for sporadic PD. The difficulty in identifying susceptibility factors in PD has not only been because of numerous underpowered studies, but we have been unable to dissect out the genetic component in a multifactorial disease. This review aims to summarize the genetic findings within PD.
引用
收藏
页码:355 / 364
页数:10
相关论文
共 50 条
  • [11] Search for molecular genetic factors in Parkinson's disease
    Shadrina, M.
    Pchelina, S.
    Illarioshkin, S.
    Slominsky, P.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 888 - 889
  • [12] A Molecular Genetic Study of Parkinson's Disease in Zambia
    Yonova, E.
    Atadzhanov, M.
    Kelly, P.
    Mwaba, P.
    Kamanga, B.
    Shawa, N.
    Simons, E.
    Breedveld, G.
    Bonifati, V.
    MOVEMENT DISORDERS, 2010, 25 : S726 - S726
  • [13] Editorial: Genetic and molecular diversity in Parkinson's disease
    Murad, Nor Azian Abdul
    Sulaiman, Siti Aishah
    Ahmad-Annuar, Azlina
    Ibrahim, Norlinah Mohamed
    Mohamed, Wael
    Md Rani, Shahrul Azmin
    Mok, Kin Ying
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [14] Integrating Pathways of Parkinson's Disease in a Molecular Interaction Map
    Kazuhiro A. Fujita
    Marek Ostaszewski
    Yukiko Matsuoka
    Samik Ghosh
    Enrico Glaab
    Christophe Trefois
    Isaac Crespo
    Thanneer M. Perumal
    Wiktor Jurkowski
    Paul M. A. Antony
    Nico Diederich
    Manuel Buttini
    Akihiko Kodama
    Venkata P. Satagopam
    Serge Eifes
    Antonio del Sol
    Reinhard Schneider
    Hiroaki Kitano
    Rudi Balling
    Molecular Neurobiology, 2014, 49 : 88 - 102
  • [15] Integrating Pathways of Parkinson's Disease in a Molecular Interaction Map
    Fujita, Kazuhiro A.
    Ostaszewski, Marek
    Matsuoka, Yukiko
    Ghosh, Samik
    Glaab, Enrico
    Trefois, Christophe
    Crespo, Isaac
    Perumal, Thanneer M.
    Jurkowski, Wiktor
    Antony, Paul M. A.
    Diederich, Nico
    Buttini, Manuel
    Kodama, Akihiko
    Satagopam, Venkata P.
    Eifes, Serge
    del Sol, Antonio
    Schneider, Reinhard
    Kitano, Hiroaki
    Balling, Rudi
    MOLECULAR NEUROBIOLOGY, 2014, 49 (01) : 88 - 102
  • [16] Genetic Analysis of Pathways to Parkinson Disease
    Hardy, John
    NEURON, 2010, 68 (02) : 201 - 206
  • [17] A Review of Genetic and Gene Therapy for Parkinson's Disease
    Dumbhare, Omkar
    Gaurkar, Sagar S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [18] Parkinson's disease pathogenesis, evolution and alternative pathways: A review
    Alexoudi, A.
    Alexoudi, I.
    Gatzonis, S.
    REVUE NEUROLOGIQUE, 2018, 174 (10) : 699 - 704
  • [19] Molecular insights into Parkinson's disease and type 2 diabetes mellitus: Metformin's role and genetic pathways explored
    Liu, Tingting
    Wu, Haojie
    Wei, Jianshe
    EXPERIMENTAL NEUROLOGY, 2025, 385
  • [20] Pathways of Parkinson's disease
    Moran, L. B.
    Graeber, M. B.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2008, 34 : 15 - 15